News Sentiment

RADX sentiment intelligence

Radiopharm Theranostics Limited American Depositary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 29 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.37 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 20

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +2.3% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

A$5,885,131 R&D tax refund supports Radiopharm Theranostics (Nasdaq: RADX)

Market Reaction

Balanced read

51/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 2.3% over four weeks
Fair value -14.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 23
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 20
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
Stock Titan 4
MarketBeat 3
GlobeNewswire 3
dars.gov.et 2
simplywall.st 2
The Globe and Mail 1
TradingKey 1

Event Lens

What the news is about

Classified themes
Market update 18
Earnings 9
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-29 of 29